3,4-dihydroxyphenylacetic acid has been researched along with caprylates in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, T; Imai, Y; Itoyama, Y; Kato, H; Takahashi, A | 1 |
| Araki, T; Kato, H; Kurosaki, R; Oki, C | 1 |
| Araki, T; Himeda, T; Kadoguchi, N; Kamiyama, Y; Kato, H; Maegawa, H | 1 |
| Joniec-Maciejak, I; Maciejak, P; Mirowska-Guzel, D; Płaźnik, A; Sobolewska, A; Szyndler, J; Turzyńska, D; Wawer, A | 1 |
4 other study(ies) available for 3,4-dihydroxyphenylacetic acid and caprylates
| Article | Year |
|---|---|
Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2003 |
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Cell Communication; Dopamine; Glial Fibrillary Acidic Protein; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Microglia; Movement Disorders; MPTP Poisoning; Neurons; Neuroprotective Agents; S100 Proteins | 2004 |
Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain; Brain Chemistry; Caprylates; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Interactions; Homovanillic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Models, Biological; Motor Activity; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Superoxide Dismutase; Time Factors; Tyrosine 3-Monooxygenase | 2006 |
Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Caprylates; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Mice; Neuroprotective Agents; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP) | 2018 |